Corey Henshaw, Matthew Gray, Kim Tam Bui, Anthony Linton. Selective Serotonin Receptor (5‐HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical Audit. // Asia-Pacific Journal of Clinical Oncology. – 2026. – DOI: 10.1111/ajco.70208. – URL: https://onlinelibrary.wiley.com/doi/10.1111/ajco.70208?af=R
Corey Henshaw, Matthew Gray, Kim Tam Bui, & Anthony Linton (2026). Selective Serotonin Receptor (5‐HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical Audit. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.70208
Corey Henshaw, et al. “Selective Serotonin Receptor (5‐HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical Audit.” Asia-Pacific Journal of Clinical Oncology, 2026. doi:10.1111/ajco.70208.
@article{Henshaw2026,
title = {Selective Serotonin Receptor (5‐HT3) Antagonist Prescribing in Cancer Inpatients: A Retrospective Clinical Audit},
author = {Henshaw, Corey and Gray, Matthew and Bui, Kim Tam and Linton, Anthony},
journal = {Asia-Pacific Journal of Clinical Oncology},
year = {2026},
doi = {10.1111/ajco.70208},
url = {https://onlinelibrary.wiley.com/doi/10.1111/ajco.70208?af=R}
}